Skip to main
UNH

UnitedHealth Group (UNH) Stock Forecast & Price Target

UnitedHealth Group (UNH) Analyst Ratings

Based on 24 analyst ratings
Buy
Strong Buy 25%
Buy 54%
Hold 13%
Sell 8%
Strong Sell 0%

Bulls say

UnitedHealth Group demonstrates a positive financial outlook, with overall earnings projected to grow 13% in 2026, primarily due to margin improvements within the Medicare and commercial segments. The company's Optum franchises are expected to contribute significantly, with Optum Health earnings anticipated to grow approximately 9% and overall margins expanding across its three business segments. Additionally, effective vertical integration enhances UnitedHealth's competitive positioning and supports its substantial scale in the medical insurance market.

Bears say

The analysis indicates a negative outlook for UnitedHealth Group, driven primarily by anticipated declines in membership across multiple segments, particularly in Medicare Advantage (MA) and Medicaid, where member counts are projected to shrink significantly by 1.3-1.4 million and 300,000 respectively due to factors such as increased plan shopping and policy changes. Furthermore, the expected decrease in MA reimbursement rates in FY2027, which is approximately 0.09% and significantly below initial optimistic forecasts, adds pressure to profitability as margins are predicted to fall, particularly in Medicaid where margins could drop from -0.1% to -1.8%. Lastly, the company faces potential political challenges as reimbursement rates are under scrutiny, with the threat of further declines in stakeholder trust if they are unable to align rates with inflationary trends and rising utilization demands.

UnitedHealth Group (UNH) has been analyzed by 24 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 54% recommend Buy, 13% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of UnitedHealth Group and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About UnitedHealth Group (UNH) Forecast

Analysts have given UnitedHealth Group (UNH) a Buy based on their latest research and market trends.

According to 24 analysts, UnitedHealth Group (UNH) has a Buy consensus rating as of Mar 17, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $373.12, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $373.12, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

UnitedHealth Group (UNH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.